ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Esperion Announces Commercial Availability of NEXLIZET americanpharmaceuticalreview
June 15, 2020Esperion announced NEXLIZETTM (bempedoic acid and ezetimibe) tablets, the first approved oral, once-daily, non-statin LDL-Cholesterol (LDL-C) lowering combination medicine is now available in the U.S.
Pharma Sources Insight January 2025
